Imatinib

MedChem Express

Imatinib [152459-95-5]

10

152459-95-5

Research Use Only

99.95

C29H31N7O

493.60

Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL , v-Abl , PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively [1] [2] [3] [4] . Imatinib also is an inhibitor of SARS-CoV and MERS-CoV [5] .

CN(CC1)CCN1CC2=CC=C(C(NC3=CC=C(C)C(NC4=NC(C5=CC=CN=C5)=CC=N4)=C3)=O)C=C2

-20°C,2°C to 8°C

12352200